GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (TSE:4543) » Definitions » Cyclically Adjusted PS Ratio

Terumo (TSE:4543) Cyclically Adjusted PS Ratio : 6.24 (As of May. 16, 2024)


View and export this data going back to 1982. Start your Free Trial

What is Terumo Cyclically Adjusted PS Ratio?

As of today (2024-05-16), Terumo's current share price is 円2795.00. Terumo's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was 円447.94. Terumo's Cyclically Adjusted PS Ratio for today is 6.24.

The historical rank and industry rank for Terumo's Cyclically Adjusted PS Ratio or its related term are showing as below:

TSE:4543' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 3.51   Med: 5.31   Max: 7.83
Current: 6.05

During the past years, Terumo's highest Cyclically Adjusted PS Ratio was 7.83. The lowest was 3.51. And the median was 5.31.

TSE:4543's Cyclically Adjusted PS Ratio is ranked worse than
75.74% of 474 companies
in the Medical Devices & Instruments industry
Industry Median: 2.185 vs TSE:4543: 6.05

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Terumo's adjusted revenue per share data for the three months ended in Mar. 2024 was 円160.853. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is 円447.94 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Terumo Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Terumo's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Terumo Cyclically Adjusted PS Ratio Chart

Terumo Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.62 5.76 5.02 4.37 6.05

Terumo Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.37 5.45 4.61 5.26 6.05

Competitive Comparison of Terumo's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Terumo's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Terumo's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Terumo's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Terumo's Cyclically Adjusted PS Ratio falls into.



Terumo Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Terumo's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=2795.00/447.94
=6.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Terumo's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Terumo's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=160.853/107.2000*107.2000
=160.853

Current CPI (Mar. 2024) = 107.2000.

Terumo Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 75.658 98.000 82.761
201409 77.923 98.500 84.806
201412 83.739 97.900 91.694
201503 77.944 97.900 85.348
201506 79.459 98.400 86.565
201509 81.013 98.500 88.168
201512 85.130 98.100 93.027
201603 81.702 97.900 89.463
201606 80.026 98.100 87.449
201609 77.466 98.000 84.738
201612 83.079 98.400 90.509
201703 91.798 98.100 100.313
201706 92.143 98.500 100.282
201709 96.097 98.800 104.267
201712 100.749 99.400 108.655
201803 99.624 99.200 107.658
201806 94.273 99.200 101.876
201809 93.333 99.900 100.153
201812 104.847 99.700 112.734
201903 102.969 99.700 110.715
201906 100.811 99.800 108.286
201909 102.125 100.100 109.369
201912 107.544 100.500 114.714
202003 104.903 100.300 112.120
202006 86.737 99.900 93.075
202009 100.418 99.900 107.756
202012 109.253 99.300 117.945
202103 109.169 99.900 117.146
202106 113.477 99.500 122.259
202109 114.266 100.100 122.371
202112 118.183 100.100 126.566
202203 118.800 101.100 125.968
202206 130.399 101.800 137.316
202209 136.440 103.100 141.866
202212 143.634 104.100 147.911
202303 135.730 104.400 139.370
202306 144.481 105.200 147.228
202309 153.445 106.200 154.890
202312 160.624 106.800 161.226
202403 160.853 107.200 160.853

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Terumo  (TSE:4543) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Terumo Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Terumo's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Terumo (TSE:4543) Business Description

Traded in Other Exchanges
Address
2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072
Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.

Terumo (TSE:4543) Headlines

No Headlines